Anti-Microbial Savior BioteQ Co., Ltd (6864.TWO)
TWD 62.5
(-0.16%)
TWD 62.5
(-0.16%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 728 Thousand | 2.69 Million | 88 Thousand | 73 Thousand | - |
| Cost of Revenue | 399 Thousand | 1.4 Million | 41 Thousand | 2000.00 | - |
| Gross Profit | 329 Thousand | 1.29 Million | 47 Thousand | 71 Thousand | - |
| Operating Expenses | 329 Thousand | 44.66 Million | 28.35 Million | 18.07 Million | -10.3 Million |
| Selling, General and Administrative Expenses | 15.12 Million | 13.03 Million | 7.13 Million | 2.3 Million | - |
| Research and Development Expenses | 45.11 Million | 31.63 Million | 21.21 Million | 15.77 Million | - |
| Other Expenses | - | 2.32 Million | 308 Thousand | 459 Thousand | -10.3 Million |
| Cost and Expenses | 60.63 Million | 46.06 Million | 28.39 Million | 18.07 Million | -10.3 Million |
| Operating Income | -56.74 Million | -39.72 Million | -27.21 Million | -17.38 Million | -10.3 Million |
| Interest Expense | 42 Thousand | 82 Thousand | 89 Thousand | 69 Thousand | - |
| Income Tax Expense | -5 Million | -8.07 Million | -4.95 Million | -3.48 Million | - |
| Earnings before Tax | -56.79 Million | -39.8 Million | -27.3 Million | -17.45 Million | - |
| Net Income | -51.78 Million | -31.73 Million | -22.35 Million | -13.97 Million | - |
| Earnings Per Share Basic | -2.05 | -1.27 | -1.18 | -1.64 | -1.13 |
| Earnings Per Share Diluted | -2.05 | -1.27 | -1.18 | -1.64 | -1.13 |
| Weighted Average Shares Outstanding | 25.26 Million | 25.02 Million | 18.86 Million | 8.52 Million | 8 Million |
| Weighted Average Shares Outstanding (Diluted) | 25.26 Million | 25.02 Million | 18.86 Million | 8.52 Million | 8 Million |
| Gross Margin | 0.45 | 0.48 | 0.53 | 0.97 | - |
| EBIT Margin | -63.52 | -11.19 | -222.92 | -155.27 | - |
| Profit Margin | -71.13 | -11.77 | -253.99 | -191.37 | - |
| EBITDA | -46.24 Million | -30.17 Million | -19.61 Million | -11.33 Million | -10.3 Million |
| Earnings Before Tax Margin | -77.95 | -14.73 | -309.28 | -238.14 | - |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Revenue | 345 Thousand | 728 Thousand | 193 Thousand | 535 Thousand | 2.69 Million | 1.31 Million |
| Cost of Revenue | 5.53 Million | 399 Thousand | 5.3 Million | 5.6 Million | 1.4 Million | 5.76 Million |
| Gross Profit | -5.18 Million | 329 Thousand | -5.1 Million | -5.06 Million | 1.29 Million | -4.45 Million |
| Operating Expenses | 27.05 Million | 60.23 Million | 27.22 Million | 22.5 Million | 44.66 Million | 20.02 Million |
| Selling, General and Administrative Expenses | 2.95 Million | - | 3.82 Million | 789 Thousand | - | 1.52 Million |
| Research and Development Expenses | 24.1 Million | - | 23.4 Million | 21.71 Million | - | 18.5 Million |
| Other Expenses | - | 1.36 Million | - | - | 2.32 Million | - |
| Cost and Expenses | 32.58 Million | 60.63 Million | 32.52 Million | 28.1 Million | 46.06 Million | 25.79 Million |
| Operating Income | -32.24 Million | -56.74 Million | -32.33 Million | -27.57 Million | -39.72 Million | -24.47 Million |
| Interest Expense | 18 Thousand | 42 Thousand | 16 Thousand | 26 Thousand | 82 Thousand | 45 Thousand |
| Income Tax Expense | 843 Thousand | -5 Million | 5000.00 | -5.01 Million | -8.07 Million | -4.72 Million |
| Earnings before Tax | -31.41 Million | -56.79 Million | -31.24 Million | -25.55 Million | -39.8 Million | -23.86 Million |
| Net Income | -31.41 Million | -51.78 Million | -31.24 Million | -20.53 Million | -31.73 Million | -19.13 Million |
| Earnings Per Share Basic | -1.10 | - | -1.24 | -0.81 | - | -0.76 |
| Earnings Per Share Diluted | -1.10 | - | -1.24 | -0.80 | - | -0.76 |
| Weighted Average Shares Outstanding | 28.55 Million | 28.44 Million | 25.26 Million | 25.26 Million | 25.02 Million | 25.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 28.55 Million | 28.44 Million | 25.26 Million | 25.63 Million | 25.02 Million | 25.26 Million |
| Gross Margin | -15.03 | 0.45 | -26.47 | -9.47 | 0.48 | -3.38 |
| EBIT Margin | -75.49 | - | -134.85 | -37.79 | - | -14.27 |
| Profit Margin | -91.07 | -71.13 | -161.90 | -38.39 | -11.77 | -14.54 |
| EBITDA | -26.04 Million | - | -26.02 Million | -20.21 Million | - | -18.77 Million |
| Earnings Before Tax Margin | -93.46 | -77.95 | -167.53 | -51.54 | -14.73 | -18.60 |
INDSWFTLAB
002358
CIS
BRRLY
GICHSGFIN
BC8